Bullish signal on daily chart
Company has no debt since last 5 years. (Source: Standalone Financials)
Loading...
Abbott India Share Price
Advertisment
Stock Recommendations
Potential
Upside1 Year
Target
STRONG BUY
Mean Recos by
6 Analysts
Unlock Potential Upside
Stock Reports Plus
/10
Stock Score
View Report
| Earnings | |
| Fundamentals | |
| Relative Valuation | |
| Risk | |
| Price Momentum |
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score
Abbott India share price insights
Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Abbott India Ltd. share price moved up by 0.57% from its previous close of Rs 31,630.00. Abbott India Ltd. stock last traded price is 31,810.00
Share Price Value Today/Current/Last 31,810.00 Previous Day 31,630.00
Key Metrics
PE Ratio (x) | 47.62 | ||||||||||
EPS - TTM (₹) | 665.64 | ||||||||||
MCap (₹ Cr.) | 67,360.18 | ||||||||||
Sectoral MCap Rank | 9 | ||||||||||
PB Ratio (x) | 15.91 | ||||||||||
Div Yield (%) | 1.50 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.58 | ||||||||||
VWAP (₹) | 31,787.16 | ||||||||||
52W H/L (₹) |
Abbott India Share Price Returns
| 1 Day | 0.57% |
| 1 Week | 3.94% |
| 1 Month | 5.45% |
| 3 Months | 3.39% |
| 1 Year | 15.69% |
| 3 Years | 76.16% |
| 5 Years | 94.98% |
Abbott India News & Analysis
Abbott India Share Recommendations
Recent Recos
STRONG BUY
Current
Mean Recos by 6 Analysts
Strong
SellSellHoldBuyStrong
Buy
SellSellHoldBuyStrong
Buy
- Target₹31420
- OrganizationAxis Securities
- BUY
- Target₹29200
- OrganizationICICI Securities
- BUY
Analyst Trends
| Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 |
| Buy | 2 | 2 | 2 | 2 |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 6 | 5 | 5 | 4 |
View all
Stock Recommendations
Abbott India Financials
Insights
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Quarterly | Annual Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Total Income 1,680.61 1,686.03 1,693.15 1,624.94 1,519.78 Total Income Growth (%) -0.32 -0.42 4.20 6.92 1.81 Total Expenses 1,193.98 1,196.18 1,211.22 1,184.97 1,127.29 Total Expenses Growth (%) -0.18 -1.24 2.22 5.12 5.61 EBIT 486.63 489.85 481.93 439.97 392.49 EBIT Growth (%) -0.66 1.64 9.54 12.10 -7.72 Profit after Tax (PAT) 367.04 360.78 358.61 328.01 287.06 PAT Growth (%) 1.74 0.61 9.33 14.27 -7.69 EBIT Margin (%) 28.96 29.05 28.46 27.08 25.83 Net Profit Margin (%) 21.84 21.40 21.18 20.19 18.89 Basic EPS (₹) 172.72 169.78 168.76 154.36 135.09 All figures in Rs Cr, unless mentioned otherwise
Insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 Total Assets 5,917.31 5,193.49 4,555.51 4,224.12 3,840.45 Total Assets Growth (%) 13.94 14.00 7.85 9.99 8.28 Total Liabilities 1,684.16 1,494.60 1,366.97 1,404.33 1,238.29 Total Liabilities Growth (%) 12.68 9.34 -2.66 13.41 11.04 Total Equity 4,233.15 3,698.89 3,188.54 2,819.79 2,602.16 Total Equity Growth (%) 14.44 16.01 13.08 8.36 7.01 Current Ratio (x) 3.39 2.42 2.51 3.20 3.41 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 0.00 106.52 106.06 123.78 123.51 All figures in Rs Cr, unless mentioned otherwise
Insights
Cash from Operations vs PAT
Operating cash flow of Rs 1011.84 cr is 0.72 times compared to the reported net profit of Rs 1414.44 cr. (Source: Standalone Financials)
Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 Net Cash flow from Operating Activities 1,011.84 1,212.81 893.39 947.66 726.74 Net Cash used in Investing Activities 182.18 -416.03 -147.71 -395.84 -71.82 Net Cash flow from Financing Activities -925.17 -744.71 -638.72 -637.38 -581.79 Net Cash Flow 268.85 52.07 106.96 -85.56 73.13 Closing Cash & Cash Equivalent 560.59 291.74 239.67 132.71 218.27 Closing Cash & Cash Equivalent Growth (%) 92.15 21.73 80.60 -39.20 50.39 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 Return on Equity (%) 33.41 32.47 29.77 28.32 26.54 Return on Capital Employed (%) 42.09 42.33 38.50 36.37 33.60 Return on Assets (%) 23.90 23.12 20.84 18.90 17.98 Interest Coverage Ratio (x) 172.37 136.66 85.04 60.99 51.65 Asset Turnover Ratio (x) 1.15 1.20 1.22 1.22 112.22 Price to Earnings (x) 46.30 47.85 49.50 47.17 46.30 Price to Book (x) 15.43 15.48 14.72 13.34 12.24 EV/EBITDA (x) 32.32 32.40 33.09 29.93 29.37 EBITDA Margin (%) 30.74 29.08 25.42 23.68 23.25
Abbott India Share Price Forecast
Get multiple analysts’ prediction on Abbott India
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
START FREE TRIALGet multiple analysts’ prediction on Abbott India
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
START FREE TRIALGet multiple analysts’ prediction on Abbott India
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
START FREE TRIAL
Abbott India Technicals
Bullish / Bearish signals for Abbott India basis selected technical indicators and moving average crossovers.
10 Day EMA Crossover
Appeared on: 2 Jun 2025
10D EMA: 30504.70
Last 4 Buy Signals:13 May 2025Date 7 days Gain/Loss % 13 May 2025 3.65% 7 May 2025 0.59% 2 May 2025 0.85% 15 Apr 2025 1.42% Average price gain of 2.53% within 7 days of Bullish signal in last 5 years
14 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 2 Jun 2025
14D EMA: 30500.57
Last 4 Buy Signals:13 May 2025Date 7 days Gain/Loss % 13 May 2025 3.65% 7 May 2025 0.59% 2 May 2025 0.85% 15 Apr 2025 1.42% Average price gain of 2.45% within 7 days of Bullish signal in last 5 years
Show More- 44%Positive Movement since
1st Jan 2005 on basis56%Negative Movement since
1st Jan 2005 on basisExclude Pivot Levels
R1 R2 R3 PIVOT S1 S2 S3 Classic - - - - - - - Average True Range
5 DAYS 14 DAYS 28 DAYS ATR 743.34 693.31 731.28
Abbott India Peer Comparison
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
Abbott India MF Ownership
824.22
Amount Invested (in Cr.)
2.74%
% of AUM
0.00
% Change (MoM basis)
497.88
Amount Invested (in Cr.)
1.73%
% of AUM
1.10
% Change (MoM basis)
437.69
Amount Invested (in Cr.)
1.82%
% of AUM
0.00
% Change (MoM basis)
MF Ownership as on 30 April 2025
Abbott India Corporate Actions
Meeting Date Announced on Purpose Details Aug 13, 2025 May 15, 2025 AGM - May 15, 2025 May 07, 2025 Board Meeting Audited Results & Final Dividend Feb 05, 2025 Jan 28, 2025 Board Meeting Quarterly Results Nov 07, 2024 Oct 28, 2024 Board Meeting Quarterly Results Aug 08, 2024 May 09, 2024 AGM - Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 4100% 410.0 Jul 19, 2024 May 09, 2024 Special 1450% 145.0 Jul 21, 2023 May 20, 2023 Final 1800% 180.0 Jul 21, 2023 May 19, 2023 Special 1300% 130.0 Aug 02, 2022 May 18, 2022 Final 4750% 475.0 - May 15, 2025 All Types Ex-Date Record Date Announced on Details Bonus Aug 17, 1998 Sep 20, 1998 Aug 10, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Rights - - Feb 02, 1994 Rights ratio: 1 share for every 10 held at a price of Rs 15.0 Bonus - - Jun 22, 1988 Bonus Ratio: 1 share(s) for every 1 shares held Bonus - Jul 28, 1987 Feb 02, 1987 Bonus Ratio: 1 share(s) for every 1 shares held Bonus - - Jun 22, 1984 Bonus Ratio: 3 share(s) for every 5 shares held
About Abbott India
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 67,360.18 Crore) operating in Pharmaceuticals sector. Abbott India Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024. Show More
Executives
Auditors
- MS
Munir Shaikh
ChairmanSDSwati Dalal
Managing DirectorAVAmbati Venu
Non Executive DirectorKMKaiyomarz Marfatia
Non Executive DirectorShow More - SRBC & Co LLP
Industry
Key Indices Listed on
Nifty 500, BSE 500, Nifty Pharma, + 25 more
Address
3, Corporate Park,Sion-Trombay Road,Mumbai, Maharashtra - 400071
More Details
FAQs about Abbott India share
- 1. What's Abbott India share price today and what are Abbott India share returns ?As on 09 Jun, 2025, 03:57 PM IST Abbott India share price is up by 0.57% basis the previous closing price of Rs 31,695. Abbott India share price is Rs 31,810.00. Return Performance of Abbott India Shares:
- 1 Week: Abbott India share price moved up by 3.94%
- 1 Month: Abbott India share price moved up by 5.45%
- 3 Month: Abbott India share price moved up by 3.39%
- 6 Month: Abbott India share price moved up by 9.27%
- 2. What are the returns for Abbott India share?Return Performance of Abbott India Shares:
- 1 Week: Abbott India share price moved up by 3.94%
- 1 Month: Abbott India share price moved up by 5.45%
- 3 Month: Abbott India share price moved up by 3.39%
- 6 Month: Abbott India share price moved up by 9.27%
- 3. Who owns Abbott India?Promoter, DII and FII owns 74.99, 8.94 and 0.17 shares of Abbott India as on 31 Mar 2025
- There is no change in promoter holding from 31 Dec 2024 to 31 Mar 2025
- Domestic Institutional Investors holding have gone down from 8.94 (31 Dec 2024) to 8.89 (31 Mar 2025)
- Foreign Institutional Investors holding have gone down from 0.17 (31 Dec 2024) to 0.16 (31 Mar 2025)
- Other investor holding has gone up from 15.9 (31 Dec 2024) to 15.96 (31 Mar 2025)
- 4. What is Abbott India's 52 week high / low?52 Week high of Abbott India share is Rs 32,200.00 while 52 week low is Rs 25,325.00
- 5. What is the CAGR of Abbott India?The CAGR of Abbott India is 6.84.
- 6. What are the key metrics to analyse Abbott India Share Price?Abbott India share can be quickly analyzed on following metrics:
- Stock's PE is 47.62
- Price to Book Ratio of 15.91
- 7. What are the Abbott India quarterly results?On Standalone basis, Abbott India reported a total income and loss of Rs 1680.61 Cr and Rs 367.04 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2025-03-31 was Rs 6684.73 Cr and Rs 1414.44 Cr.
- 8. Should I buy, sell or hold Abbott India?As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 5 analysts for Abbott India stock is to Strong Buy. Recommendation breakup is as follows
- 3 analysts are recommending Strong Buy
- 2 analysts are recommending to Buy
- 9. Which are the key peers to Abbott India?Within Pharmaceuticals sector Abbott India, GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Ltd., AstraZeneca Pharma India Ltd., Sanofi India Ltd., Sanofi Consumer Healthcare India Ltd. and Procter & Gamble Health Ltd. are usually compared together by investors for analysis.
- 10. What's the market capitalization of Abbott India?Abbott India share has a market capitalization of Rs 67,360.18 Cr. Within Pharmaceuticals sector, it's market cap rank is 9.
- 11. What dividend is Abbott India giving?Abbott India Ltd. announced an equity dividend of 4100% on a face value of 10.0 amounting to Rs 410 per share on 09 May 2024. The ex dividend date was 19 Jul 2024.
- 12. What is the PE & PB ratio of Abbott India?The PE ratio of Abbott India stands at 47.52, while the PB ratio is 15.88.
- 13. Who's the chairman of Abbott India?Munir Shaikh is the Chairman of Abbott India
Trending in Markets
Top Gainers As on 03:59 PM | 09 Jun 2025
Top Losers As on 03:59 PM | 09 Jun 2025
Abbott India Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.
